Oncology [TOI] vs HCA Healthcare [HCA] Detailed Stock Comparison

The Oncology Institute Inc.

NASDAQ
Loading...

HCA Healthcare Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: The Oncology Institute Inc. wins in 7 metrics, HCA Healthcare Inc. wins in 11 metrics, with 0 ties. HCA Healthcare Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric The Oncology Institute Inc. HCA Healthcare Inc. Better
P/E Ratio (TTM) N/A 16.86 N/A
Price-to-Book Ratio -20.91 -38.44 The Oncology Institute Inc.
Debt-to-Equity Ratio -6.60 -17.57 The Oncology Institute Inc.
PEG Ratio -21.50 0.37 HCA Healthcare Inc.
EV/EBITDA -14.08 10.08 HCA Healthcare Inc.
Profit Margin (TTM) -12.06% 8.97% HCA Healthcare Inc.
Operating Margin (TTM) -4.87% 16.29% HCA Healthcare Inc.
EBITDA Margin (TTM) N/A 16.29% N/A
Return on Equity 320.01% -244.82% The Oncology Institute Inc.
Return on Assets (TTM) -13.37% 12.44% HCA Healthcare Inc.
Free Cash Flow (TTM) $-27.79M $7.69B HCA Healthcare Inc.
Dividend Yield N/A 0.59% N/A
1-Year Return 114.98% 4.31% The Oncology Institute Inc.
Price-to-Sales Ratio (TTM) 0.68 1.39 The Oncology Institute Inc.
Enterprise Value $410.19M $156.18B HCA Healthcare Inc.
EV/Revenue Ratio 0.82 2.07 The Oncology Institute Inc.
Gross Profit Margin (TTM) 16.04% 41.90% HCA Healthcare Inc.
Revenue per Share (TTM) $5 $320 HCA Healthcare Inc.
Earnings per Share (Diluted) $-0.54 $27.94 HCA Healthcare Inc.
Beta (Stock Volatility) 0.20 1.37 The Oncology Institute Inc.
Short % of Float 10.12% 2.45% HCA Healthcare Inc.

The Oncology Institute Inc. vs HCA Healthcare Inc. Stock Performance Analysis

Loading Price Chart...

TOI
HCA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
The Oncology Institute Inc.-2.45%2.17%30.15%51.91%37.40%41.14%
HCA Healthcare Inc.0.72%7.93%-7.81%-25.75%-18.24%-17.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
The Oncology Institute Inc.114.98%756.45%-47.43%-46.04%-46.04%-46.04%
HCA Healthcare Inc.4.31%33.47%92.28%400.04%1,019.34%1,144.15%

Performance & Financial Health Analysis: The Oncology Institute Inc. vs HCA Healthcare Inc.

MetricTOIHCA
Market Information
Market Cap i$323.20M$106.00B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,461,731795,641
90 Day Avg. Volume i2,155,547974,074
Last Close$5.18$389.97
52 Week Range$2.02 - $5.57$330.00 - $556.52
% from 52W High-7.09%-29.93%
All-Time High$12.66 (Dec 27, 2021)$556.52 (Mar 12, 2026)
% from All-Time High-59.08%-29.93%
Growth Metrics
Quarterly Revenue Growth0.42%0.07%
Quarterly Earnings Growth0.42%0.31%
Financial Health
Profit Margin (TTM) i-0.12%0.09%
Operating Margin (TTM) i-0.05%0.16%
Return on Equity (TTM) i3.20%-2.45%
Debt to Equity (MRQ) i-6.60-17.57
Cash & Liquidity
Book Value per Share (MRQ)$-0.16$-26.83
Cash per Share (MRQ)$0.34$5.11
Operating Cash Flow (TTM) i$-24,587,000$12.64B
Levered Free Cash Flow (TTM) i$-11,004,375$5.82B
Dividends
Last 12-Month Dividend Yield iN/A0.59%
Last 12-Month Dividend iN/A$2.94

Valuation & Enterprise Metrics Analysis: The Oncology Institute Inc. vs HCA Healthcare Inc.

MetricTOI (Apr 24, 2026)HCA (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) iN/A16.86
Forward P/E i-21.5014.13
PEG Ratio i-21.500.37
Price to Sales (TTM) i0.681.39
Price to Book (MRQ) i-20.91-38.44
Market Capitalization
Market Capitalization i$323.20M$106.00B
Enterprise Value i$410.19M$156.18B
Enterprise Value Metrics
Enterprise to Revenue i0.822.07
Enterprise to EBITDA i-14.0810.08
Risk & Other Metrics
Beta i0.201.37
Book Value per Share (MRQ) i$-0.16$-26.83

Financial Statements Comparison: The Oncology Institute Inc. vs HCA Healthcare Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTOI (2025)HCA (2025)
Revenue/Sales i502.73M75.60B
Cost of Goods Sold i426.29M44.23B
COGS % of Revenue i84.8%58.5%
Gross Profit i76.44M31.37B
Gross Margin i15.2%41.5%
Research & Development iN/AN/A
Operating Income (EBIT) i-36.08M11.97B
Operating Margin i-7.2%15.8%
EBITDA i-30.06M15.57B
EBITDA Margin i-6.0%20.6%
Pre-Tax Income i-60.74M9.83B
Pre-Tax Income % of Revenue i-12.1%13.0%
Income Tax i-131,0002.05B
Income Tax % of Revenue i0.0%2.7%
Net Income (Profit) i-60.61M7.78B
Profit Margin i-12.1%10.3%

Balance Sheet & Liquidity Metrics

MetricTOI (2025)HCA (2025)
Cash & Equivalents i33.57M1.04B
Total Current Assets i112.75M15.78B
Total Current Assets % of Revenue i22.4%20.9%
Total Current Liabilities i70.96M16.35B
Total Current Liabilities % of Revenue i14.1%21.6%
Long-Term Debt i96.53M43.46B
Long-Term Debt % of Revenue i19.2%57.5%
Total Shareholders Equity i-15.72M-2.77B
Retained Earnings i-271.42M-5.72B
Retained Earnings % of Revenue i-54.0%-7.6%
Property, Plant & Equipment i24.08M39.12B

Cash Flow Statement Comparison

MetricTOI (2025)HCA (2025)
Operating Cash Flow i-41.02M12.01B
Operating Cash Flow % of Revenue i-8.2%15.9%
Capital Expenditures i-3.20M-4.94B
Free Cash Flow i-27.79M7.69B
FCF Margin i-5.5%10.2%
Debt Repayment i-20.04M-7.39B
Common Stock Repurchase iN/A-10.07B

Short Interest & Institutional Ownership Analysis

MetricTOIHCA
Shares Short i8.30M3.63M
Short Ratio i3.363.37
Short % of Float i10.12%2.45%
Shares Outstanding i98.86M224.61M
Float Shares i64.83M151.19M
% Held by Insiders i20.14%16.16%
% Held by Institutions i45.02%78.70%
% Held by Public i34.84%5.14%

Dividend Analysis & Yield Comparison: The Oncology Institute Inc. vs HCA Healthcare Inc.

MetricTOIHCA
Last 12-Month Dividend iN/A$2.94
Last 12-Month Dividend Yield iN/A0.59%
3-Year Avg Annual Dividend iN/A$2.70
3-Year Avg Dividend Yield iN/A0.19%
3-Year Total Dividends iN/A$8.10
Ex-Dividend DateN/AMar 17, 2026